BACKGROUND: Annotation and Image Markup on ClearCanvas Enriched Stroke-phenotyping Software (ACCESS) is a novel stand-alone computer software application that allows the creation of simple standardized annotations for reporting brain images of all stroke types. We developed the ACCESS application and determined its inter-rater and intra-rater reliability in the Stroke Investigative Research and Educational Network (SIREN) study to assess its suitability for multicenter studies. METHODS: One hundred randomly selected stroke imaging reports from 5 SIREN sites were re-evaluated by 4 trained independent raters to determine the inter-rater reliability of the ACCESS (version 12.0) software for stroke phenotyping. To determine intra-rater reliability, 6 raters reviewed the same cases previously reported by them after a month of interval. Ischemic stroke was classified using the Oxfordshire Community Stroke Project (OCSP), Trial of Org 10172 in Acute Stroke Treatment (TOAST), and Atherosclerosis, Small-vessel disease, Cardiac source, Other cause (ASCO) protocols, while hemorrhagic stroke was classified using the Structural lesion, Medication, Amyloid angiopathy, Systemic disease, Hypertensive angiopathy and Undetermined (SMASH-U) protocol in ACCESS. Agreement among raters was measured with Cohen's kappa statistics. RESULTS: For primary stroke type, inter-rater agreement was .98 (95% confidence interval [CI], .94-1.00), while intra-rater agreement was 1.00 (95% CI, 1.00). For OCSP subtypes, inter-rater agreement was .97 (95% CI, .92-1.00) for the partial anterior circulation infarcts, .92 (95% CI, .76-1.00) for the total anterior circulation infarcts, and excellent for both lacunar infarcts and posterior circulation infarcts. Intra-rater agreement was .97 (.90-1.00), while inter-rater agreement was .93 (95% CI, .84-1.00) for TOAST subtypes. Inter-rater agreement ranged between .78 (cardioembolic) and .91 (large artery atherosclerotic) for ASCO subtypes and was .80 (95% CI, .56-1.00) for SMASH-U subtypes. CONCLUSION: The ACCESS application facilitates a concordant and reproducible classification of stroke subtypes by multiple investigators, making it suitable for clinical use and multicenter research.
BACKGROUND: Annotation and Image Markup on ClearCanvas Enriched Stroke-phenotyping Software (ACCESS) is a novel stand-alone computer software application that allows the creation of simple standardized annotations for reporting brain images of all stroke types. We developed the ACCESS application and determined its inter-rater and intra-rater reliability in the Stroke Investigative Research and Educational Network (SIREN) study to assess its suitability for multicenter studies. METHODS: One hundred randomly selected stroke imaging reports from 5 SIREN sites were re-evaluated by 4 trained independent raters to determine the inter-rater reliability of the ACCESS (version 12.0) software for stroke phenotyping. To determine intra-rater reliability, 6 raters reviewed the same cases previously reported by them after a month of interval. Ischemic stroke was classified using the Oxfordshire Community Stroke Project (OCSP), Trial of Org 10172 in Acute Stroke Treatment (TOAST), and Atherosclerosis, Small-vessel disease, Cardiac source, Other cause (ASCO) protocols, while hemorrhagic stroke was classified using the Structural lesion, Medication, Amyloid angiopathy, Systemic disease, Hypertensive angiopathy and Undetermined (SMASH-U) protocol in ACCESS. Agreement among raters was measured with Cohen's kappa statistics. RESULTS: For primary stroke type, inter-rater agreement was .98 (95% confidence interval [CI], .94-1.00), while intra-rater agreement was 1.00 (95% CI, 1.00). For OCSP subtypes, inter-rater agreement was .97 (95% CI, .92-1.00) for the partial anterior circulation infarcts, .92 (95% CI, .76-1.00) for the total anterior circulation infarcts, and excellent for both lacunar infarcts and posterior circulation infarcts. Intra-rater agreement was .97 (.90-1.00), while inter-rater agreement was .93 (95% CI, .84-1.00) for TOAST subtypes. Inter-rater agreement ranged between .78 (cardioembolic) and .91 (large artery atherosclerotic) for ASCO subtypes and was .80 (95% CI, .56-1.00) for SMASH-U subtypes. CONCLUSION: The ACCESS application facilitates a concordant and reproducible classification of stroke subtypes by multiple investigators, making it suitable for clinical use and multicenter research.
Authors: E M Arsava; E Ballabio; T Benner; J W Cole; M P Delgado-Martinez; M Dichgans; F Fazekas; K L Furie; K Illoh; K Jood; S Kittner; A G Lindgren; J J Majersik; M J Macleod; W J Meurer; J Montaner; A A Olugbodi; A Pasdar; P Redfors; R Schmidt; P Sharma; A B Singhal; A G Sorensen; C Sudlow; V Thijs; B B Worrall; J Rosand; H Ay Journal: Neurology Date: 2010-10-05 Impact factor: 9.910
Authors: Atte Meretoja; Daniel Strbian; Jukka Putaala; Sami Curtze; Elena Haapaniemi; Satu Mustanoja; Tiina Sairanen; Jarno Satopää; Heli Silvennoinen; Mika Niemelä; Markku Kaste; Turgut Tatlisumak Journal: Stroke Date: 2012-08-02 Impact factor: 7.914
Authors: David S Channin; Pattanasak Mongkolwat; Vladimir Kleper; Kastubh Sepukar; Daniel L Rubin Journal: J Digit Imaging Date: 2009-03-18 Impact factor: 4.056
Authors: Richard Idro; Amelia K Boehme; Michael Kawooya; Samson K Lubowa; Deogratias Munube; Paul Bangirana; Robert Opoka; Ezekiel Mupere; Angela Lignelli; Philip Kasirye; Nancy S Green; Frank J Minja Journal: J Stroke Cerebrovasc Dis Date: 2022-02-11 Impact factor: 2.136
Authors: R Akinyemi; H K Tiwari; D K Arnett; B Ovbiagele; M R Irvin; K Wahab; F Sarfo; V Srinivasasainagendra; A Adeoye; R T Perry; A Akpalu; C Jenkins; O Arulogun; M Gebregziabher; L Owolabi; R Obiako; E Sanya; M Komolafe; M Fawale; P Adebayo; G Osaigbovo; T Sunmonu; P Olowoyo; I Chukwuonye; Y Obiabo; A Onoja; J Akinyemi; G Ogbole; S Melikam; R Saulson; M Owolabi Journal: Acta Neurol Scand Date: 2017-10-03 Impact factor: 3.209
Authors: Rajesh N Kalaria; Mayowa O Owolabi; Rufus O Akinyemi; Bruce Ovbiagele; Olaleye A Adeniji; Fred S Sarfo; Foad Abd-Allah; Thierry Adoukonou; Okechukwu S Ogah; Pamela Naidoo; Albertino Damasceno; Richard W Walker; Adesola Ogunniyi Journal: Nat Rev Neurol Date: 2021-09-15 Impact factor: 42.937